VIDA is focused on transforming pulmonary care through intelligence. Powered by a unique combination of AI and quality-controlled image analysis services, VIDA’s solution aims to provide greater precision and personalization across a range of lung diseases including cancer, emphysema, airway obstructive diseases, asthma and interstitial lung disease. LungPrintTM is part of the VIDA|vision® Software Suite and available for clinical use in the USA, EU, Canada and Australia. More at www.vidadiagnostics.com.
